Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2015. Start Trial.
Date Value
October 23, 2026 1.022
October 22, 2026 0.9733
October 21, 2026 1.051
October 20, 2026 1.051
October 19, 2026 1.042
October 16, 2026 0.9733
October 15, 2026 1.051
October 14, 2026 0.9928
October 13, 2026 1.032
October 12, 2026 1.042
October 09, 2026 1.071
October 08, 2026 1.071
October 07, 2026 1.071
October 06, 2026 1.042
October 05, 2026 1.071
October 02, 2026 1.080
October 01, 2026 1.080
September 30, 2026 1.090
September 29, 2026 1.119
September 28, 2026 1.119
September 25, 2026 1.090
September 24, 2026 1.110
September 23, 2026 1.119
September 22, 2026 1.119
September 21, 2026 1.132
Date Value
September 18, 2026 1.158
September 17, 2026 1.129
September 16, 2026 1.129
September 15, 2026 1.139
September 14, 2026 1.139
September 11, 2026 1.188
September 10, 2026 1.188
September 09, 2026 1.119
September 08, 2026 1.144
September 04, 2026 1.139
September 03, 2026 1.188
September 02, 2026 1.188
September 01, 2026 1.188
August 31, 2026 1.188
August 28, 2026 1.188
August 27, 2026 1.180
August 26, 2026 1.188
August 25, 2026 1.178
August 24, 2026 1.148
August 21, 2026 1.168
August 20, 2026 1.188
August 19, 2026 1.197
August 18, 2026 1.168
August 17, 2026 1.168
August 14, 2026 1.188

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 20.32
Anika Therapeutics, Inc. 2.088
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.376

Price to Book Value Related Metrics

Price 1.05
Earnings Yield -4.45%
Market Cap 12.28M